Publications by authors named "Andrew Leuchter"

97Publications

Resting EEG theta connectivity and alpha power to predict repetitive transcranial magnetic stimulation response in depression: A non-replication from the ICON-DB consortium.

Clin Neurophysiol 2020 Nov 10. Epub 2020 Nov 10.

Epworth Centre for Innovation in Mental Health, Epworth Healthcare, The Epworth Clinic, Camberwell, Victoria 3004, Australia; Monash University, Department of Psychiatry, Central Clinical School, Commercial Rd, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinph.2020.10.018DOI Listing
November 2020

Strategies for augmentation of high-frequency left-sided repetitive transcranial magnetic stimulation treatment of major depressive disorder.

J Affect Disord 2020 Dec 8;277:964-969. Epub 2020 Sep 8.

TMS Clinical and Research Service, Neuromodulation Division, Semel Institute for Neuroscience and Human Behavior, and the Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, 760 Westwood Plaza, Los Angeles, CA 90024, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jad.2020.09.011DOI Listing
December 2020

Sequential multi-locus transcranial magnetic stimulation for treatment of obsessive-compulsive disorder with comorbid major depression: A case series.

Brain Stimul 2020 Oct 13. Epub 2020 Oct 13.

TMS Clinical and Research Program, Neuromodulation Division, Semel Institute for Neuroscience and Human Behavior at UCLA, Los Angeles, CA, USA; Department of Psychiatry & Biobehavioral Sciences, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.brs.2020.10.003DOI Listing
October 2020

EEG multifractal analysis correlates with cognitive testing scores and clinical staging in mild cognitive impairment.

J Clin Neurosci 2020 Jun 16;76:195-200. Epub 2020 Apr 16.

Greater Los Angeles VA Dept. of Nuclear Imaging, University of California, Irvine, United States; Dept. of Physics, University of California, Irvine, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jocn.2020.04.003DOI Listing
June 2020

Prospective testing of a neurophysiologic biomarker for treatment decisions in major depressive disorder: The PRISE-MD trial.

J Psychiatr Res 2020 05 26;124:159-165. Epub 2020 Feb 26.

Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine at UCLA, 760 Westwood Plaza, Los Angeles, CA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpsychires.2020.02.028DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141143PMC
May 2020

Effect of repetitive transcranial magnetic stimulation (rTMS) treatment of major depressive disorder (MDD) on cognitive control.

J Affect Disord 2020 Mar 15;265:272-277. Epub 2020 Jan 15.

TMS Clinical and Research Program, Neuromodulation Division, Semel Institute for Neuroscience and Human Behavior at UCLA, Los Angeles, CA, United States; Department of Psychiatry & Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jad.2020.01.068DOI Listing
March 2020

Benzodiazepine Use and rTMS Outcome.

Am J Psychiatry 2020 02;177(2):172

Department of Psychiatry and Biobehavioral Sciences, Neuromodulation Division, TMS Clinical and Research Service, and Laboratory of Brain, Behavior, and Pharmacology, Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine at UCLA, Los Angeles.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1176/appi.ajp.2019.19060603DOI Listing
February 2020

EEG Spectral Features in Sleep of Autism Spectrum Disorders in Children with Tuberous Sclerosis Complex.

J Autism Dev Disord 2020 Mar;50(3):916-923

Department of Neurology, Harvard Medical School, Harvard University, 300 Longwood Avenue, Boston, MA, 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10803-019-04326-0DOI Listing
March 2020

Time Course of Changes in Peripheral Blood Gene Expression During Medication Treatment for Major Depressive Disorder.

Front Genet 2019 18;10:870. Epub 2019 Sep 18.

Neuromodulation Division, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, Los Angeles, CA, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fgene.2019.00870DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6760033PMC
September 2019

The relationship between individual alpha peak frequency and clinical outcome with repetitive Transcranial Magnetic Stimulation (rTMS) treatment of Major Depressive Disorder (MDD).

Brain Stimul 2019 Nov - Dec;12(6):1572-1578. Epub 2019 Jul 25.

TMS Clinical and Research Program, Neuromodulation Division, Semel Institute for Neuroscience and Human Behavior at UCLA, Los Angeles, CA, USA; Department of Psychiatry & Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S1935861X193030
Publisher Site
http://dx.doi.org/10.1016/j.brs.2019.07.018DOI Listing
February 2020

Increased electroencephalography connectivity precedes epileptic spasm onset in infants with tuberous sclerosis complex.

Epilepsia 2019 08 12;60(8):1721-1732. Epub 2019 Jul 12.

Division of Epilepsy and Clinical Neurophysiology, Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/epi.16284DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6687536PMC
August 2019

Dorsolateral prefrontal γ-aminobutyric acid in patients with treatment-resistant depression after transcranial magnetic stimulation measured with magnetic resonance spectroscopy

J Psychiatry Neurosci 2019 Nov;44(6):386-394

From the Neuromodulation Division, Semel Institute for Neuroscience and Human Behavior at UCLA, Los Angeles (Levitt, Diaz, Cook, Ginder, Krantz, Minzenberg, Vince-Cruz, Nguyen, Leuchter); the Department of Psychiatry & Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles (Levitt, Kalender, O’Neill, Cook, Krantz, Minzenberg, Leuchter); the Department of Neurosurgery, David Geffen School of Medicine at UCLA, Los Angeles (Kalender); the Division of Child and Adolescent Psychiatry, Semel Institute for Neuroscience and Human Behavior at UCLA, Los Angeles (Levitt, O’Neill); the Department of Bioengineering, Henry Samueli School of Engineering at Applied Science at UCLA, Los Angeles (Cook); the Department of Neurology, UCLA David Geffen School of Medicine at UCLA, Los Angeles (Alger); the Advanced Imaging Research Center, University of Texas Southwestern Medical Center, Dallas, Texas (Alger); and the NeuroSpectroScopics, LCC, Sherman Oaks, California (Alger).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1503/jpn.180230DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6821508PMC
November 2019

Grief, Mindfulness and Neural Predictors of Improvement in Family Dementia Caregivers.

Front Hum Neurosci 2019 14;13:155. Epub 2019 May 14.

Department of Psychiatry and Biobehavioral Sciences, UCLA Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fnhum.2019.00155DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530345PMC
May 2019

Changes in Functional Connectivity Predict Outcome of Repetitive Transcranial Magnetic Stimulation Treatment of Major Depressive Disorder.

Cereb Cortex 2019 12;29(12):4958-4967

TMS Clinical and Research Program, Neuromodulation Division, Semel Institute for Neuroscience and Human Behavior at UCLA, Los Angeles CA 90024, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/cercor/bhz035DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305800PMC
December 2019

Concomitant medication use and clinical outcome of repetitive Transcranial Magnetic Stimulation (rTMS) treatment of Major Depressive Disorder.

Brain Behav 2019 05 2;9(5):e01275. Epub 2019 Apr 2.

Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, University of California Los Angeles, Los Angeles, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/brb3.1275DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6520297PMC
May 2019

Double-Blind, Sham-Controlled, Pilot Study of Trigeminal Nerve Stimulation for Attention-Deficit/Hyperactivity Disorder.

J Am Acad Child Adolesc Psychiatry 2019 04 28;58(4):403-411.e3. Epub 2019 Jan 28.

Semel Institute for Neuroscience and Human Behavior and the David Geffen School of Medicine at the University of California, Los Angeles (UCLA), Los Angeles, CA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S08908567193004
Publisher Site
http://dx.doi.org/10.1016/j.jaac.2018.11.013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481187PMC
April 2019

Brain Activity and Clinical Outcomes in Adults With Depression Treated With Synchronized Transcranial Magnetic Stimulation: An Exploratory Study.

Neuromodulation 2019 Dec 13;22(8):894-897. Epub 2019 Jan 13.

Semel Institute for Neuroscience and Human Behavior, University of California Los Angeles, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/ner.12914
Publisher Site
http://dx.doi.org/10.1111/ner.12914DOI Listing
December 2019

A systematic literature review of the clinical efficacy of repetitive transcranial magnetic stimulation (rTMS) in non-treatment resistant patients with major depressive disorder.

BMC Psychiatry 2019 01 8;19(1):13. Epub 2019 Jan 8.

University of California Los Angeles (UCLA), Neuromodulation Division, Semel Institute for Neuroscience and Human Behavior, UCLA, 760 Westwood Plaza, Room 37-452, Los Angeles, CA, 90095, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12888-018-1989-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325728PMC
January 2019

Predictors of response to synchronized transcranial magnetic stimulation for major depressive disorder.

Depress Anxiety 2019 03 27;36(3):278-285. Epub 2018 Nov 27.

Butler Hospital Mood Disorders Research Program and Neuromodulation Research Facility, Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University, Providence, RI, 02906, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/da.22862
Publisher Site
http://dx.doi.org/10.1002/da.22862DOI Listing
March 2019

A precision medicine approach to repetitive Transcranial Magnetic Stimulation (rTMS).

Brain Stimul 2018 May - Jun;11(3):463-464. Epub 2018 Feb 16.

Neuromodulation Division, Semel Institute for Neuroscience and Human Behavior, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, 760 Westwood Plaza, 57-463, Los Angeles, CA 90095, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.brs.2018.02.003DOI Listing
February 2018

Change in Quantitative EEG Theta Cordance as a Potential Predictor of Repetitive Transcranial Magnetic Stimulation Clinical Outcome in Major Depressive Disorder.

Clin EEG Neurosci 2018 Sep 10;49(5):306-315. Epub 2017 Dec 10.

1 Laboratory of Brain, Behavior, and Pharmacology, TMS Clinical and Research Program, Neuromodulation Division, Semel Institute at UCLA, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1550059417746212DOI Listing
September 2018

Cost effectiveness analysis comparing repetitive transcranial magnetic stimulation to antidepressant medications after a first treatment failure for major depressive disorder in newly diagnosed patients - A lifetime analysis.

PLoS One 2017 26;12(10):e0186950. Epub 2017 Oct 26.

Neuromodulation Division, Semel Institute for Neuroscience and Human Behavior, University California Los Angeles, Los Angeles, CA, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0186950PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5658110PMC
December 2017

Evaluating cognitive complaints in breast cancer survivors with the FACT-Cog and quantitative electroencephalography.

Breast Cancer Res Treat 2017 Nov 13;166(1):157-166. Epub 2017 Jul 13.

UCLA Jonsson Comprehensive Cancer Center, 650 Charles Young Drive South, Room A2-125 CHS, Los Angeles, CA, 90095-6900, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-017-4390-6DOI Listing
November 2017

Defining Treatment-Resistant Depression.

JAMA Psychiatry 2017 07;74(7):758-759

Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, The David Geffen School of Medicine at University of California, Los Angeles.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamapsychiatry.2017.0967DOI Listing
July 2017

Can neurophysiologic measures serve as biomarkers for the efficacy of repetitive transcranial magnetic stimulation treatment of major depressive disorder?

Int Rev Psychiatry 2017 04 31;29(2):98-114. Epub 2017 Mar 31.

a David Geffen School of Medicine , University of California Los Angeles , Los Angeles , CA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/09540261.2017.1297697DOI Listing
April 2017

Escitalopram but not placebo modulates brain rhythmic oscillatory activity in the first week of treatment of Major Depressive Disorder.

J Psychiatr Res 2017 01 7;84:174-183. Epub 2016 Oct 7.

Neuromodulation Division, and Laboratory of Brain, Behavior, and Pharmacology, Semel Institute for Neuroscience and Human Behavior at University of California Los Angeles (UCLA), Los Angeles, CA 90024, United States; Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA 90024, United States; Department of Bioengineering, University of California Los Angeles, Los Angeles, CA 90095, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpsychires.2016.10.002DOI Listing
January 2017

Escitalopram but not placebo modulates brain rhythmic oscillatory activity in the first week of treatment of Major Depressive Disorder.

J Psychiatr Res 2017 01 7;84:174-183. Epub 2016 Oct 7.

Neuromodulation Division, and Laboratory of Brain, Behavior, and Pharmacology, Semel Institute for Neuroscience and Human Behavior at University of California Los Angeles (UCLA), Los Angeles, CA 90024, United States; Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA 90024, United States; Department of Bioengineering, University of California Los Angeles, Los Angeles, CA 90095, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpsychires.2016.10.002DOI Listing
January 2017

Treatment-refractory posttraumatic stress disorder (TRPTSD): a review and framework for the future.

Prog Neuropsychopharmacol Biol Psychiatry 2016 10 6;70:170-218. Epub 2016 Feb 6.

Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, Los Angeles, USA; Semel Institute for Neuroscience and Human behavior at UCLA, 760 Westwood Plaza, Los Angeles, CA 90024, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pnpbp.2016.01.015DOI Listing
October 2016

Trigeminal Nerve Stimulation for Comorbid Posttraumatic Stress Disorder and Major Depressive Disorder.

Neuromodulation 2016 Apr 28;19(3):299-305. Epub 2016 Jan 28.

Neuromodulation Division, Semel Institute for Neuroscience and Human Behavior at UCLA, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ner.12399DOI Listing
April 2016

Authors' reply.

Br J Psychiatry 2015 Dec;207(6):561-2

Andrew F. Leuchter, Semel Institute for Neuroscience and Human Behavior at UCLA, Director of Neuromodulation Division, Los Angeles, USA. Email: Aimee M. Hunter, Molly Tartter, Ian A. Cook, UCLA, Los Angeles, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1192/bjp.207.6.561bDOI Listing
December 2015

Antidepressant treatment history and drug-placebo separation in a placebo-controlled trial in major depressive disorder.

Psychopharmacology (Berl) 2015 Oct 29;232(20):3833-40. Epub 2015 Aug 29.

Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, University of California Los Angeles, 760 Westwood Plaza, Rm. 57-455, Los Angeles, CA, 90024-1759, USA,

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s00213-015-4047
Web Search
http://link.springer.com/10.1007/s00213-015-4047-2
Publisher Site
http://dx.doi.org/10.1007/s00213-015-4047-2DOI Listing
October 2015

Author's reply: To PMID 25213159.

Br J Psychiatry 2015 May;206(5):435

Andrew F. Leuchter, MD, Aimee M. Hunter, PhD, Molly Tartter, PhD, Ian A. Cook, MD, University of California - Los Angeles. Email:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1192/bjp.206.5.435DOI Listing
May 2015

Rhythms and blues: modulation of oscillatory synchrony and the mechanism of action of antidepressant treatments.

Ann N Y Acad Sci 2015 May 23;1344:78-91. Epub 2015 Mar 23.

Laboratory of Brain, Behavior, and Pharmacology, and the Depression Research and Clinic Program, Semel Institute for Neuroscience and Human Behavior at UCLA, Los Angeles, California; Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/nyas.12742DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4412810PMC
May 2015

Intermediate phenotypes and biomarkers of treatment outcome in major depressive disorder.

Dialogues Clin Neurosci 2014 Dec;16(4):525-37

Laboratory of Brain, Behavior, and Pharmacology, and the Depression Research and Clinical Program, Semel Institute for Neuroscience and Human Behavior, UCLA; the Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, UCLA; the Department of Bioengineering, Henry Samueli School of Engineering and Applied Sciences, UCLA, Los Angeles, California, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4336921PMC
December 2014

An eight-week, open-trial, pilot feasibility study of trigeminal nerve stimulation in youth with attention-deficit/hyperactivity disorder.

Brain Stimul 2015 Mar-Apr;8(2):299-304. Epub 2014 Nov 28.

Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.brs.2014.11.013DOI Listing
May 2015

The Antidepressant Treatment Response Index as a Predictor of Reboxetine Treatment Outcome in Major Depressive Disorder.

Clin EEG Neurosci 2015 Oct 24;46(4):277-84. Epub 2014 Sep 24.

Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, CA, USA Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles, CA, USA

View Article

Download full-text PDF

Source
http://escholarship.org/uc/item/2db9q2mz.pdf
Web Search
http://eeg.sagepub.com/content/46/4/277.full.pdf
Web Search
http://eeg.sagepub.com/lookup/doi/10.1177/1550059414532443
Publisher Site
http://dx.doi.org/10.1177/1550059414532443DOI Listing
October 2015

Role of pill-taking, expectation and therapeutic alliance in the placebo response in clinical trials for major depression.

Br J Psychiatry 2014 Dec 11;205(6):443-9. Epub 2014 Sep 11.

Andrew F. Leuchter, MD, Aimee M. Hunter, PhD, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA and the Laboratory of Brain, Behavior, and Pharmacology, Semel Institute for Neuroscience and Human Behavior at UCLA, Los Angeles; Molly Tartter, MA, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, the Laboratory of Brain, Behavior, and Pharmacology, Semel Institute for Neuroscience and Human Behavior at UCLA and the Department of Psychology, University of California Los Angeles, Los Angeles; Ian A. Cook, MD, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA and the Laboratory of Brain, Behavior, and Pharmacology, Semel Institute for Neuroscience and Human Behavior at UCLA, Los Angeles, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1192/bjp.bp.113.140343DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4248233PMC
December 2014

Quantitative electroencephalography biomarkers of cognitive complaints after adjuvant therapy in breast cancer survivors: a pilot study.

Psychooncology 2014 Jun 6;23(6):713-5. Epub 2014 Feb 6.

Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA; Laboratory of Brain, Behavior, and Pharmacology, UCLA, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pon.3487DOI Listing
June 2014

Heart rate variability and treatment outcome in major depression: a pilot study.

Int J Psychophysiol 2014 Aug 24;93(2):204-10. Epub 2014 Apr 24.

Psychophysiology Laboratory, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, CA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijpsycho.2014.04.006DOI Listing
August 2014

Neurophysiologic predictors of response to atomoxetine in young adults with attention deficit hyperactivity disorder: a pilot project.

J Psychiatr Res 2014 Jul 27;54:11-8. Epub 2014 Mar 27.

Department of Psychiatry and Biobehavioral Sciences, and the Laboratory of Brain, Behavior, and Pharmacology, Semel Institute for Neuroscience and Human Behavior at UCLA, Los Angeles, CA, USA; UCLA Depression Research and Clinic Program, Semel Institute for Neuroscience and Human Behavior at UCLA, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://escholarship.org/uc/item/9bw4d88j.pdf
Web Search
http://linkinghub.elsevier.com/retrieve/pii/S002239561400082
Publisher Site
http://dx.doi.org/10.1016/j.jpsychires.2014.03.009DOI Listing
July 2014

Do prefrontal midline electrodes provide unique neurophysiologic information in Major Depressive Disorder?

J Psychiatr Res 2014 Jun 11;53:69-75. Epub 2014 Feb 11.

UCLA Depression Research & Clinic Program, Semel Institute for Neuroscience and Human Behavior at UCLA, Brain Research Institute, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, United States; Laboratory of Brain, Behavior, and Pharmacology, Semel Institute for Neuroscience and Human Behavior at UCLA, Brain Research Institute, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpsychires.2014.01.018DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333308PMC
June 2014

Neuromodulation for depression: invasive and noninvasive (deep brain stimulation, transcranial magnetic stimulation, trigeminal nerve stimulation).

Neurosurg Clin N Am 2014 Jan;25(1):103-16

UCLA Depression Research & Clinic Program, Semel Institute for Neuroscience and Human Behavior at UCLA, David Geffen School of Medicine at UCLA, Henry Samueli School of Engineering at UCLA, 760 Westwood Plaza, Los Angeles, CA 90095, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10423680130010
Publisher Site
http://dx.doi.org/10.1016/j.nec.2013.10.002DOI Listing
January 2014

Neurophysiologic effects of repeated exposure to antidepressant medication: are brain functional changes during antidepressant administration influenced by learning processes?

Med Hypotheses 2013 Dec 17;81(6):1004-11. Epub 2013 Sep 17.

Laboratory of Brain, Behavior, and Pharmacology, and the UCLA Depression Research & Clinic Program, Semel Institute for Neuroscience and Human Behavior at UCLA, Los Angeles, CA, USA; Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mehy.2013.09.016DOI Listing
December 2013

Assessment of the feasibility of a rehabilitation intervention program for breast cancer survivors with cognitive complaints.

Brain Imaging Behav 2013 Dec;7(4):543-53

Department of Psychiatry and Biobehavioral Sciences and Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA,

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11682-013-9237-0
Publisher Site
http://dx.doi.org/10.1007/s11682-013-9237-0DOI Listing
December 2013

Trigeminal nerve stimulation in major depressive disorder: acute outcomes in an open pilot study.

Epilepsy Behav 2013 Aug 14;28(2):221-6. Epub 2013 Jun 14.

UCLA Depression Research & Clinic Program, Semel Institute for Neuroscience and Human Behavior at UCLA, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.yebeh.2013.05.008DOI Listing
August 2013

A genome-wide association study of a sustained pattern of antidepressant response.

J Psychiatr Res 2013 Sep 30;47(9):1157-65. Epub 2013 May 30.

Department of Psychiatry, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpsychires.2013.05.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3710535PMC
September 2013

Rostral anterior cingulate activity in major depressive disorder: state or trait marker of responsiveness to medication?

J Neuropsychiatry Clin Neurosci 2013 ;25(2):126-33

Laboratory of Brain, Behavior, and Pharmacology, and UCLA Depression Research & Clinic Program, Semel Institute for Neuroscience and Human Behavior at UCLA, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1176/appi.neuropsych.11110330DOI Listing
January 2014

The relationship between brain oscillatory activity and therapeutic effectiveness of transcranial magnetic stimulation in the treatment of major depressive disorder.

Front Hum Neurosci 2013 26;7:37. Epub 2013 Feb 26.

Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, Semel Institute for Neuroscience and Human Behavior, University of California Los Angeles Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fnhum.2013.00037DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3581824PMC
April 2013

Quantitative electroencephalogram biomarkers for predicting likelihood and speed of achieving sustained remission in major depression: a report from the biomarkers for rapid identification of treatment effectiveness in major depression (BRITE-MD) trial.

J Clin Psychiatry 2013 Jan;74(1):51-6

UCLA Semel Institute for Neuroscience and Human Behavior, Depression Research & Clinic Program and Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4088/JCP.10m06813DOI Listing
January 2013

Predictive socioeconomic and clinical profiles of antidepressant response and remission.

Depress Anxiety 2013 Jul 3;30(7):624-30. Epub 2013 Jan 3.

Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, California 90024, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/da.22045
Publisher Site
http://dx.doi.org/10.1002/da.22045DOI Listing
July 2013

Does prior antidepressant treatment of major depression impact brain function during current treatment?

Eur Neuropsychopharmacol 2012 Oct 23;22(10):711-20. Epub 2012 Mar 23.

Laboratory of Brain, Behavior, and Pharmacology, and the Depression Research and Clinic Program, Semel Institute for Neuroscience and Human Behavior, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, UCLA, Los Angeles, CA 90024-1759, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.euroneuro.2012.02.005DOI Listing
October 2012

Resting-state quantitative electroencephalography reveals increased neurophysiologic connectivity in depression.

PLoS One 2012 24;7(2):e32508. Epub 2012 Feb 24.

Laboratory of Brain, Behavior, and Pharmacology, Semel Institute for Neuroscience and Human Behavior, University of California Los Angeles, Los Angeles, California, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0032508PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3286480PMC
August 2012

Effects of heart disease on depression treatment: results from the COMED study.

Gen Hosp Psychiatry 2012 Jan-Feb;34(1):24-34. Epub 2011 Oct 15.

Department of Psychiatry, University of Michigan, Ann Arbor, MI 48109, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01638343110028
Publisher Site
http://dx.doi.org/10.1016/j.genhosppsych.2011.08.018DOI Listing
June 2012

The antidepressant treatment response index and treatment outcomes in a placebo-controlled trial of fluoxetine.

J Clin Neurophysiol 2011 Oct;28(5):478-82

Laboratory of Brain, Behavior, and Pharmacology, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, Los Angeles, California 90024-1759, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/WNP.0b013e318230da8aDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3188349PMC
October 2011

Rostral anterior cingulate cortex activity and early symptom improvement during treatment for major depressive disorder.

Psychiatry Res 2011 Jun 4;192(3):188-94. Epub 2011 May 4.

Labrotory of Brain, Behavior, and Pharmacology, and the UCLA Depression Research for Clinic Program, Semel Institute for Neuroscience and Human Behavior at UCLA, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pscychresns.2010.12.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3152489PMC
June 2011

QEEG Measures in Huntington's Disease: A Pilot Study.

PLoS Curr 2010 Oct 25;2:RRN1192. Epub 2010 Oct 25.

UCLA School of Medicine; Department of Neurology UCLA; UCLA Semel Institute and UCLA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1371/currents.RRN1192DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2964156PMC
October 2010

Biomarkers to predict antidepressant response.

Curr Psychiatry Rep 2010 Dec;12(6):553-62

Semel Institute for Neuroscience and Human Behavior at UCLA, David Geffen School of Medicine at UCLA, Los Angeles, CA 90024, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11920-010-0160-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2965366PMC
December 2010

Amygdala lateralization at rest and during viewing of neutral faces in major depressive disorder using low-resolution brain electromagnetic tomography.

Clin EEG Neurosci 2010 Jan;41(1):19-23

Semel Institute for Neuroscience and Human Behavior at UCLA, Los Angeles, CA 90024-1759, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/155005941004100106DOI Listing
January 2010

A new paradigm for the prediction of antidepressant treatment response.

Dialogues Clin Neurosci 2009 ;11(4):435-46

Laboratory of Brain Behavior, and Pharmacology, Semel Institute for Neuroscience and Human Behavior at UCLA, Los Angeles, CA 90024, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181929PMC
March 2010

Midline and right frontal brain function as a physiologic biomarker of remission in major depression.

Psychiatry Res 2009 Nov 22;174(2):152-7. Epub 2009 Oct 22.

UCLA Depression Research & Clinic Program, Semel Institute for Neuroscience and Human Behavior at UCLA, Los Angeles, CA, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pscychresns.2009.04.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2804067PMC
November 2009

Quantitative EEG abnormalities are associated with memory impairment in recently abstinent methamphetamine-dependent individuals.

J Neuropsychiatry Clin Neurosci 2009 ;21(3):254-8

Baylor College of Medicine, Menninger Department of Psychiatry and Behavioral Sciences, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1176/jnp.2009.21.3.254DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3350803PMC
December 2009

Antidepressant response trajectories and quantitative electroencephalography (QEEG) biomarkers in major depressive disorder.

J Psychiatr Res 2010 Jan 24;44(2):90-8. Epub 2009 Jul 24.

Semel Institute for Neuroscience and Human Behavior at UCLA, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, CA 90024-1759, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpsychires.2009.06.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2925497PMC
January 2010

Monoamine oxidase a and catechol-o-methyltransferase functional polymorphisms and the placebo response in major depressive disorder.

J Clin Psychopharmacol 2009 Aug;29(4):372-7

Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA,760 Westwood Plaza, Rm 37-452, Los Angeles, CA 90024-1759, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JCP.0b013e3181ac4aafDOI Listing
August 2009

Rostral anterior cingulate cortex theta current density and response to antidepressants and placebo in major depression.

Clin Neurophysiol 2009 Jul 17;120(7):1313-9. Epub 2009 Jun 17.

Laboratory of Brain, Behavior, and Pharmacology, Semel Institute for Neuroscience and Human Behavior at UCLA, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, CA 90024-1759, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinph.2009.05.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2710394PMC
July 2009

Use of clinical neurophysiology for the selection of medication in the treatment of major depressive disorder: the state of the evidence.

Clin EEG Neurosci 2009 Apr;40(2):78-83

Laboratory of Brain, Behavior, and Pharmacology, Semel Institute for Neuroscience and Human Behavior at UCLA, Los Angeles, CA 90024-1759, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/155005940904000207DOI Listing
April 2009

Brain functional changes and duloxetine treatment response in fibromyalgia: a pilot study.

Pain Med 2009 May-Jun;10(4):730-8. Epub 2009 Apr 22.

Laboratory of Brain, Behavior, and Pharmacology, Semel Institute for Neuroscience and Human Behavior at the University of California, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1526-4637.2009.00614.xDOI Listing
November 2009

Changes in brain function during administration of venlafaxine or placebo to normal subjects.

Clin EEG Neurosci 2008 Oct;39(4):175-81

Laboratory of Brain, Behavior, and Pharmacology, Semel Institute for Neuroscience and Human Behavior at UCLA, Los Angeles, CA 90024-1759, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/155005940803900405DOI Listing
October 2008

Brain electrical source differences between depressed subjects and healthy controls.

Brain Topogr 2008 Dec 29;21(2):138-46. Epub 2008 Oct 29.

Laboratory of Brain, Behavior, and Pharmacology, Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior at UCLA, David Geffen School of Medicine at UCLA, Los Angeles, CA 90024-1759, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10548-008-0070-5DOI Listing
December 2008

Yoga as a complementary treatment of depression: effects of traits and moods on treatment outcome.

Evid Based Complement Alternat Med 2007 Dec;4(4):493-502

Semel Institute for Neuroscience and Human Behavior, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles, CA, USA, Department of Neurophysiology, Moscow Research Center of Narcology, Moscow, Russia and Department of Psychology, University of Bologna, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ecam/nel114DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2176141PMC
December 2007

Need to strike balance with industry-academia rules.

Nature 2007 Oct;449(7163):658

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/449658cDOI Listing
October 2007

Insured and non-insured depressed outpatients: how do they compare?

Ann Clin Psychiatry 2007 Apr-Jun;19(2):73-82

Department of Psychiatry, Harbor-UCLA Medical Center, The Los Angeles Biomedical Research Institute, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10401230701334671DOI Listing
October 2007

The promise of the quantitative electroencephalogram as a predictor of antidepressant treatment outcomes in major depressive disorder.

Psychiatr Clin North Am 2007 Mar;30(1):105-24

Laboratory of Brain, Behavior, and Pharmacology, Semel Institute for Neuroscience and Human Behavior at UCLA, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, CA 90024-1759, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.psc.2006.12.002DOI Listing
March 2007

Aging and brain activation with working memory tasks: an fMRI study of connectivity.

Int J Geriatr Psychiatry 2007 Apr;22(4):332-42

UCLA Semel Institute for Neuroscience and Human Behavior, California 90024-1759, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gps.1678DOI Listing
April 2007

Changes in brain function (quantitative EEG cordance) during placebo lead-in and treatment outcomes in clinical trials for major depression.

Am J Psychiatry 2006 Aug;163(8):1426-32

Semel Institute for Neuroscience and Human Behavior at UCLA, 760 Westwood Plaza, Rm. 37-359, Los Angeles, CA 90024-1759, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1176/ajp.2006.163.8.1426DOI Listing
August 2006

Neurophysiologic changes during estrogen augmentation in perimenopausal depression.

Maturitas 2007 Jan 10;56(1):54-60. Epub 2006 Jul 10.

Laboratory of Brain, Behavior, and Pharmacology, Department of Psychiatry and Biobehavioral Sciences, UCLA Neuropsychiatric Institute, 760 Westwood Plaza, Suite 37-439, Los Angeles, CA 90024-1759, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.maturitas.2006.05.010DOI Listing
January 2007

Neurophysiologic changes during estrogen augmentation in perimenopausal depression.

Maturitas 2007 Jan 10;56(1):54-60. Epub 2006 Jul 10.

Laboratory of Brain, Behavior, and Pharmacology, Department of Psychiatry and Biobehavioral Sciences, UCLA Neuropsychiatric Institute, 760 Westwood Plaza, Suite 37-439, Los Angeles, CA 90024-1759, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.maturitas.2006.05.010DOI Listing
January 2007

Variation in neurophysiological function and evidence of quantitative electroencephalogram discordance: predicting cocaine-dependent treatment attrition.

J Neuropsychiatry Clin Neurosci 2006 ;18(2):208-16

Medication Development Unit, Research Service, and Psychiatry Service, West Los Angeles VA Medical Center, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1176/jnp.2006.18.2.208DOI Listing
September 2006

Does the clinical course of depression determine improvement in symptoms and quality of life?

J Nerv Ment Dis 2006 Apr;194(4):241-8

School of Social Work, University of Wisconsin-Madison, Madison, Wisconsin 53706, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.nmd.0000207358.15230.80DOI Listing
April 2006

Evaluation of reboxetine, a noradrenergic antidepressant, for the treatment of fibromyalgia and chronic low back pain.

Psychosomatics 2005 Sep-Oct;46(5):379-84

Laboratory of Behavioral Pharmacology, UCLA Neuropsychiatric Institute, 37-452 NPI, 760 Westwood Plaza, Los Angeles, CA 90024, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1176/appi.psy.46.5.379DOI Listing
November 2005

Characteristics of insured and noninsured outpatients with depression in STAR(*)D.

Psychiatr Serv 2005 Aug;56(8):995-1004

Harbor-UCLA Medical Center, Box 8, 1000 West Carson Street, Torrance, California 90509, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1176/appi.ps.56.8.995DOI Listing
August 2005

Changes in prefrontal activity characterize clinical response in SSRI nonresponders: a pilot study.

J Psychiatr Res 2005 Sep;39(5):461-6

Laboratory of Behavioral Pharmacology, UCLA Neuropsychiatric Institute, 760 Westwood Plaza, 37-451, Los Angeles, CA 90024-1759, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpsychires.2004.12.002DOI Listing
September 2005

Influence of age, gender, health status, and depression on quantitative EEG.

Neuropsychobiology 2005 29;52(2):71-6. Epub 2005 Jun 29.

Behavioral Pharmacology Laboratory, UCLA Neuropsychiatric Institute, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000086608DOI Listing
October 2005

Estrogen augmentation of antidepressants in perimenopausal depression: a pilot study.

J Clin Psychiatry 2005 Jun;66(6):774-80

Laboratory of Behavioral Pharmacology, University of California Los Angeles Neuropsychiatric Institute and Hospital, Department of Psychiatry and Biobehavioral Sciences, 90024, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4088/jcp.v66n0617DOI Listing
June 2005

Neurophysiologic correlates of side effects in normal subjects randomized to venlafaxine or placebo.

Neuropsychopharmacology 2005 Apr;30(4):792-9

Behavioral Pharmacology Laboratory, Department of Psychiatry and Biobehavioral Sciences, UCLA Neuropsychiatric Institute, David Geffen School of Medicine, Los Angeles, CA 90024-1759, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.npp.1300652DOI Listing
April 2005

Subject expectations of treatment effectiveness and outcome of treatment with an experimental antidepressant.

J Clin Psychiatry 2004 Sep;65(9):1174-9

Laboratory of Behavioral Pharmacology, UCLA Neuropsychiatric Institute, and the Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, CA 90024-1759, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4088/jcp.v65n0904DOI Listing
September 2004

Pretreatment neurophysiologic function and ECT response in depression.

J ECT 2004 Sep;20(3):142-4

Laboratory of Behavioral Pharmacology, UCLA Neuropsychiatric Institute, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, CA 90024, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00124509-200409000-00004DOI Listing
September 2004

Predictors of improved mood over time in clinical trials for major depression.

Psychiatry Res 2004 Jun;127(1-2):73-84

Department of Preventive Medicine, University of Southern California Keck School of Medicine, 1540 Alcazar St, CHP 218, Los Angeles, CA 90033-9010, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.psychres.2004.02.013DOI Listing
June 2004

Pretreatment neurophysiological and clinical characteristics of placebo responders in treatment trials for major depression.

Psychopharmacology (Berl) 2004 Dec 14;177(1-2):15-22. Epub 2004 Jul 14.

UCLA NPI, 760 Westwood Plaza, Suite 37-452, Los Angeles, CA 90024-1759, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00213-004-1919-2DOI Listing
December 2004